Company Filing History:

4 out of 40

Aktiebolaget Draco

patents

Years Active: 1983-2000

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6140308 - Colon or ileum-specific glucocorticosteroid derivatives (2000-10-31),

2. 6043236 - Estrogens (2000-03-28),

3. 5939409 - Processes for the production of anti-inflammatory steroids (1999-08-17),

4. 5908833 - Colon or ileum-specific steroid derivatives (1999-06-01),

5. 5888995 - Steroid esters (1999-03-30),

6. 5674861 - Fluorinated steroids (1997-10-07),

7. 5614514 - Steroid esters (1997-03-25),

8. 5215979 - 16,17-acetalsubstituted pregnane 21-oic acid derivatives (1993-06-01),

9. 4820700 - Novel androstane-17.beta.-carboxylic acid esters, a process and (1989-04-11),

10. 4693999 - Liposomes containing steroid esters (1987-09-15),

11. 4404200 - 4-Pregnene-derivatives, a process for their preparation, composition and (1983-09-13),

Title: Inventor Ralph Lennart Brattsand: A Trailblazer in Pharmaceutical Innovations

Introduction

Ralph Lennart Brattsand, based in Lund, Sweden, is a distinguished inventor known for his significant contributions to the field of pharmaceuticals. With an impressive portfolio of 11 patents, he has dedicated his career to developing novel compounds that improve medical treatments and patient outcomes.

Latest Patents

Among his latest patents is a groundbreaking innovation involving colon or ileum-specific glucocorticosteroid derivatives. These novel compounds feature a glucocorticosteroid chemically bound to a sugar, showcased by the general formula he developed. This innovative approach aims to enhance targeted therapies for gastrointestinal conditions.

Career Highlights

Throughout his career, Brattsand has made notable advancements in the pharmaceutical industry while working for reputable organizations such as Aktiebolaget Draco and Astra Aktiebolag. His work has not only influenced product development but has also set new standards in pharmaceutical research and innovation.

Collaborations

Brattsand has collaborated with key figures in the industry, including coworkers Bengt I Axelsson and Bror Arne Thalen. These partnerships have fostered an environment of creativity and knowledge exchange, furthering the impact of their collective work.

Conclusion

In summary, Ralph Lennart Brattsand stands as a prominent figure in the realm of pharmaceutical innovation. His extensive patent portfolio and collaborations highlight his dedication to advancing medical science, making him an inspiring inventor for future generations.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com